SWITGLIM MV 2/02 (Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg))

Switglim-MV 2/0.2 Tablet ER is classified as an anti-diabetic medication. This treatment is formulated specifically for managing type 2 diabetes mellitus in adult patients. Its primary function is to assist in regulating blood sugar levels for individuals diagnosed with diabetes. It is advised to take Switglim-MV 2/0.2 Tablet ER with food or just before meals to optimize its efficacy. Consistency in medication timing is crucial for achieving the best results; therefore, taking it at the same time each day is recommended. The prescribing physician will determine the most suitable dosage for each patient, which may require adjustments based on ongoing blood sugar monitoring. It is essential to continue using this medication as prescribed, even if you feel well or notice stable blood sugar readings. Discontinuing the drug without consulting a healthcare professional could lead to increased blood sugar levels, potentially resulting in severe complications such as kidney impairment, vision loss, nerve damage, or limb loss. This medication should be viewed as part of a broader treatment strategy that includes a balanced diet, regular physical activity, and weight management as directed by your healthcare provider, since lifestyle choices significantly impact diabetes management. Awareness of hypoglycemia symptoms, including sweating, dizziness, headaches, and tremors, is important. To mitigate the risk of low blood sugar, maintain regular meal times and have a quick source of glucose, like fruit juice or sugary snacks, accessible. Switglim-MV 2/0.2 Tablet ER may also cause various side effects, including altered taste, nausea, diarrhea, stomach discomfort, headaches, swelling, blurred vision, fractures, and respiratory tract infections. Additionally, some patients may experience weight gain while on this medication. Individuals with type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver diseases should avoid this treatment. It is also important to disclose any history of heart disease to your doctor, as it may influence treatment suitability. Pregnant and breastfeeding women are urged to seek medical advice prior to commencing this medication. Regular monitoring of blood glucose levels is essential, and healthcare providers may recommend routine blood tests to check blood cell levels and liver function.